106
Views
161
CrossRef citations to date
0
Altmetric
Article

Mammalian ALKBH8 Possesses tRNA Methyltransferase Activity Required for the Biogenesis of Multiple Wobble Uridine Modifications Implicated in Translational Decoding

, , , , , , , & show all
Pages 1814-1827 | Received 14 Dec 2009, Accepted 20 Jan 2010, Published online: 20 Mar 2023
 

Abstract

Uridines in the wobble position of tRNA are almost invariably modified. Modifications can increase the efficiency of codon reading, but they also prevent mistranslation by limiting wobbling. In mammals, several tRNAs have 5-methoxycarbonylmethyluridine (mcm5U) or derivatives thereof in the wobble position. Through analysis of tRNA from Alkbh8−/− mice, we show here that ALKBH8 is a tRNA methyltransferase required for the final step in the biogenesis of mcm5U. We also demonstrate that the interaction of ALKBH8 with a small accessory protein, TRM112, is required to form a functional tRNA methyltransferase. Furthermore, prior ALKBH8-mediated methylation is a prerequisite for the thiolation and 2′-O-ribose methylation that form 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and 5-methoxycarbonylmethyl-2′-O-methyluridine (mcm5Um), respectively. Despite the complete loss of all of these uridine modifications, Alkbh8−/− mice appear normal. However, the selenocysteine-specific tRNA (tRNASec) is aberrantly modified in the Alkbh8−/− mice, and for the selenoprotein Gpx1, we indeed observed reduced recoding of the UGA stop codon to selenocysteine.

We are very grateful to Andrzej Malkiewicz (Lodz, Poland) for providing nucleoside standards for mcm5U and mcm5s2U. We thank Alan Diamond (University of Illinois at Chicago) for providing pBPLUGA-Gpx1. pSport1-SECISBP2 was a generous gift from Laura V. Papp (Queensland Institute of Medical Research, Australia). We are grateful to Anders Bekkelund and Tine W. Abrahamsen for their help with plasmid construction and to Cecilie G. Castellanos, Guro F. Lien, and Hege Wiksen for excellent technical assistance and animal care. We thank GenOway, Lyon, France; The Norwegian Transgenic Center (NTS); and the Center for Comparative studies at Oslo University Hospital HF for the excellent service they provided.

This work was supported by grants from the FRIBIO and FUGE programs of the Research Council of Norway.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.